EOLS
Evolus, Inc.$7.84-0.09 (-1.07%)Prev Close$7.93·MCap$516.3M·P/E—·Vol352.1K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
7
$1.84M
◆
Net Activity
Net Seller
$1.84M
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Evolus, Inc. (EOLS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 7 insider sales totaling $1.84M. The most recent insider transaction was by MOATAZEDI DAVID (director, officer: See Remarks), who sold $950.0K worth of shares on Sep 4, 2026. Evolus, Inc. operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry, with a market cap of $516.3M.
EOLS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 105,108 | $9.04 | $950.0K | 499,592 |
| Mar 20, 2026 | Avelar Rui | officer: See Remarks | Sell | 3,119 | $4.75 | $14.8K | 427,423 |
| Mar 20, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 13,669 | $4.75 | $64.9K | 604,700 |
| Mar 18, 2026 | Avelar Rui | officer: See Remarks | Sell | 29,996 | $4.89 | $146.6K | 430,542 |
| Mar 18, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 116,720 | $4.89 | $570.6K | 618,369 |
| Dec 22, 2025 | Avelar Rui | See Remarks | Sell | 2,261 | $7.15 | $16.2K | 356,821 |
| Dec 22, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 10,539 | $7.15 | $75.4K | 354,388 |
| Aug 22, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 5,722 | $7.51 | $43.0K | 89,949 |
| Aug 15, 2025 | Stewart Brady | Director | Buy | 30,000 | $6.82 | $204.5K | 88,629+51% |
| Jun 13, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 127,905 | $10.03 | $1.28M | 381,509-25% |
| Jun 9, 2025 | White Albert G III | Director | Buy | 20,000 | $9.45 | $189.0K | 50,378+66% |
| May 13, 2025 | Beaver Sandra | Chief Financial Officer | Sell | 6,494 | $10.02 | $65.1K | 167,089 |
| May 12, 2025 | Avelar Rui | See Remarks | Sell | 3,385 | $9.87 | $33.4K | 359,082 |
| May 12, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 15,787 | $9.87 | $155.8K | 492,832 |
| Mar 27, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 6,251 | $12.40 | $77.5K | 508,619 |
| Mar 18, 2025 | Avelar Rui | See Remarks | Sell | 27,904 | $13.26 | $369.9K | 362,467 |
| Mar 18, 2025 | Beaver Sandra | Chief Financial Officer | Sell | 8,996 | $13.26 | $119.2K | 173,583 |
| Mar 18, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 103,376 | $13.26 | $1.37M | 514,870 |
| Mar 18, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 4,536 | $13.26 | $60.1K | 95,671 |
| Mar 12, 2025 | Parschauer Karah Herdman | Director | Sell | 12,888 | $12.99 | $167.5K | 32,183-29% |
| Dec 23, 2024 | Avelar Rui | See Remarks | Sell | 2,252 | $10.85 | $24.4K | 366,595 |
| Dec 23, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 1,586 | $10.85 | $17.2K | 146,916 |
| Dec 23, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 10,502 | $10.85 | $114.0K | 522,847 |
| Sep 6, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 3,276 | $14.98 | $49.1K | 148,502 |
| Aug 30, 2024 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 5,631 | $15.85 | $89.3K | 82,375 |
| Jun 4, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 471,432 | $12.74 | $6.01M0.7% OS | 533,349-47% |
| Jun 3, 2024 | Malik Vikram | Director | Sell | 7,500 | $12.96 | $97.2K | 246,514 |
| May 13, 2024 | GILL DAVID N | Director | Sell | 10,361 | $12.64 | $131.0K | 40,682 |
| May 13, 2024 | Malik Vikram | Director | Sell | 28,000 | $12.93 | $362.0K | 254,014 |
| May 10, 2024 | Avelar Rui | See Remarks | Sell | 3,441 | $12.72 | $43.8K | 368,847 |
| May 10, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 2,423 | $12.72 | $30.8K | 151,778 |
| May 10, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 16,051 | $12.72 | $204.1K | 673,563 |
| Mar 27, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 6,236 | $13.86 | $86.4K | 689,614 |
| Mar 19, 2024 | Avelar Rui | See Remarks | Sell | 27,603 | $13.92 | $384.4K | 372,288 |
| Mar 19, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 5,672 | $13.92 | $79.0K | 154,201 |
| Mar 19, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 96,566 | $13.92 | $1.34M | 695,850 |
| Feb 21, 2024 | Avelar Rui | See Remarks | Sell | 1,821 | $13.08 | $23.8K | 399,891 |
| Feb 21, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 1,821 | $13.08 | $23.8K | 159,873 |
| Feb 21, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 7,706 | $13.08 | $100.8K | 792,416 |
| Jan 30, 2024 | Parschauer Karah Herdman | Director | Sell | 11,931 | $13.14 | $156.7K | 31,243-28% |
| Dec 6, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 82,648 | $9.95 | $822.4K | 635,244 |
| Sep 6, 2023 | Beaver Sandra | Chief Financial Officer | Sell | 3,178 | $9.70 | $30.8K | 113,368 |
| Aug 14, 2023 | Avelar Rui | See Remarks | Sell | 2,211 | $10.27 | $22.7K | 353,386 |
| Aug 14, 2023 | Beaver Sandra | Chief Financial Officer | Sell | 2,211 | $10.27 | $22.7K | 116,546 |
| Aug 14, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 14,778 | $10.27 | $151.8K | 686,592 |
| Aug 11, 2023 | Malik Vikram | Director | Buy | 174,967 | $7.41 | $1.30M | 275,550+174% |
| Mar 27, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 6,110 | $8.47 | $51.8K | 609,567 |
| Mar 14, 2023 | Avelar Rui | See Remarks | Sell | 14,906 | $8.47 | $126.2K | 335,925 |
| Mar 14, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 64,211 | $8.47 | $543.8K | 615,677 |
| Sep 9, 2022 | HAYMAN ROBERT | Director | Buy | 10,000 | $10.39 | $103.9K | 10,000 |
Showing 1–50 of 69
1 / 2
EOLS Insider Buying Activity
The following table shows recent insider purchases of Evolus, Inc. (EOLS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Stewart Brady | Director | Buy | 30,000 | $6.82 | $204.5K | 88,629+51% |
| Jun 9, 2025 | White Albert G III | Director | Buy | 20,000 | $9.45 | $189.0K | 50,378+66% |
| Aug 11, 2023 | Malik Vikram | Director | Buy | 174,967 | $7.41 | $1.30M | 275,550+174% |
| Sep 9, 2022 | HAYMAN ROBERT | Director | Buy | 10,000 | $10.39 | $103.9K | 10,000 |
EOLS Insider Selling Activity
The following table shows recent insider sales of Evolus, Inc. (EOLS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 105,108 | $9.04 | $950.0K | 499,592 |
| Mar 20, 2026 | Avelar Rui | officer: See Remarks | Sell | 3,119 | $4.75 | $14.8K | 427,423 |
| Mar 20, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 13,669 | $4.75 | $64.9K | 604,700 |
| Mar 18, 2026 | Avelar Rui | officer: See Remarks | Sell | 29,996 | $4.89 | $146.6K | 430,542 |
| Mar 18, 2026 | MOATAZEDI DAVID | director, officer: See Remarks | Sell | 116,720 | $4.89 | $570.6K | 618,369 |
| Dec 22, 2025 | Avelar Rui | See Remarks | Sell | 2,261 | $7.15 | $16.2K | 356,821 |
| Dec 22, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 10,539 | $7.15 | $75.4K | 354,388 |
| Aug 22, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 5,722 | $7.51 | $43.0K | 89,949 |
| Jun 13, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 127,905 | $10.03 | $1.28M | 381,509-25% |
| May 13, 2025 | Beaver Sandra | Chief Financial Officer | Sell | 6,494 | $10.02 | $65.1K | 167,089 |
| May 12, 2025 | Avelar Rui | See Remarks | Sell | 3,385 | $9.87 | $33.4K | 359,082 |
| May 12, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 15,787 | $9.87 | $155.8K | 492,832 |
| Mar 27, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 6,251 | $12.40 | $77.5K | 508,619 |
| Mar 18, 2025 | Avelar Rui | See Remarks | Sell | 27,904 | $13.26 | $369.9K | 362,467 |
| Mar 18, 2025 | Beaver Sandra | Chief Financial Officer | Sell | 8,996 | $13.26 | $119.2K | 173,583 |
| Mar 18, 2025 | MOATAZEDI DAVID | See Remarks | Sell | 103,376 | $13.26 | $1.37M | 514,870 |
| Mar 18, 2025 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 4,536 | $13.26 | $60.1K | 95,671 |
| Mar 12, 2025 | Parschauer Karah Herdman | Director | Sell | 12,888 | $12.99 | $167.5K | 32,183-29% |
| Dec 23, 2024 | Avelar Rui | See Remarks | Sell | 2,252 | $10.85 | $24.4K | 366,595 |
| Dec 23, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 1,586 | $10.85 | $17.2K | 146,916 |
| Dec 23, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 10,502 | $10.85 | $114.0K | 522,847 |
| Sep 6, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 3,276 | $14.98 | $49.1K | 148,502 |
| Aug 30, 2024 | Yamagishi-Dressler Tomoko | Chief Marketing Officer | Sell | 5,631 | $15.85 | $89.3K | 82,375 |
| Jun 4, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 471,432 | $12.74 | $6.01M0.7% OS | 533,349-47% |
| Jun 3, 2024 | Malik Vikram | Director | Sell | 7,500 | $12.96 | $97.2K | 246,514 |
| May 13, 2024 | GILL DAVID N | Director | Sell | 10,361 | $12.64 | $131.0K | 40,682 |
| May 13, 2024 | Malik Vikram | Director | Sell | 28,000 | $12.93 | $362.0K | 254,014 |
| May 10, 2024 | Avelar Rui | See Remarks | Sell | 3,441 | $12.72 | $43.8K | 368,847 |
| May 10, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 2,423 | $12.72 | $30.8K | 151,778 |
| May 10, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 16,051 | $12.72 | $204.1K | 673,563 |
| Mar 27, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 6,236 | $13.86 | $86.4K | 689,614 |
| Mar 19, 2024 | Avelar Rui | See Remarks | Sell | 27,603 | $13.92 | $384.4K | 372,288 |
| Mar 19, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 5,672 | $13.92 | $79.0K | 154,201 |
| Mar 19, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 96,566 | $13.92 | $1.34M | 695,850 |
| Feb 21, 2024 | Avelar Rui | See Remarks | Sell | 1,821 | $13.08 | $23.8K | 399,891 |
| Feb 21, 2024 | Beaver Sandra | Chief Financial Officer | Sell | 1,821 | $13.08 | $23.8K | 159,873 |
| Feb 21, 2024 | MOATAZEDI DAVID | See Remarks | Sell | 7,706 | $13.08 | $100.8K | 792,416 |
| Jan 30, 2024 | Parschauer Karah Herdman | Director | Sell | 11,931 | $13.14 | $156.7K | 31,243-28% |
| Dec 6, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 82,648 | $9.95 | $822.4K | 635,244 |
| Sep 6, 2023 | Beaver Sandra | Chief Financial Officer | Sell | 3,178 | $9.70 | $30.8K | 113,368 |
| Aug 14, 2023 | Avelar Rui | See Remarks | Sell | 2,211 | $10.27 | $22.7K | 353,386 |
| Aug 14, 2023 | Beaver Sandra | Chief Financial Officer | Sell | 2,211 | $10.27 | $22.7K | 116,546 |
| Aug 14, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 14,778 | $10.27 | $151.8K | 686,592 |
| Mar 27, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 6,110 | $8.47 | $51.8K | 609,567 |
| Mar 14, 2023 | Avelar Rui | See Remarks | Sell | 14,906 | $8.47 | $126.2K | 335,925 |
| Mar 14, 2023 | MOATAZEDI DAVID | See Remarks | Sell | 64,211 | $8.47 | $543.8K | 615,677 |
EOLS Insiders
Similar Stocks to EOLS
VTRS
Viatris Inc.
$16.64-0.21%
$19.23B
ELAN
Elanco Animal Health Incorporated
$23.02-0.63%
$11.57B
AMRX
Amneal Pharmaceuticals, Inc.
$16.62-3.48%
$5.57B
INDV
Indivior Pharmaceuticals Inc
$34.10-1.06%
$4.36B
ETON
Eton Pharmaceuticals, Inc.
$54.59-5.26%
$1.61B
ANIP
ANI Pharmaceuticals, Inc.
$71.41+1.43%
$1.60B
HROW
Harrow Health, Inc.
$33.98-0.25%
$1.41B
PCRX
Pacira BioSciences, Inc.
$23.81-3.48%
$1.02B